Pacer Advisors, Inc. Seagen Inc. Transaction History

Pacer Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $391,637 - $442,047	2,045 Added 36.04%	7,719 $1.64 Million
Q2 2023 Jul 12, 2023	SELL	$187.64 - $206.25 $922,250 - $1.01 Million	-4,915 Reduced 46.42%	5,674 $1.09 Million
Q1 2023 May 02, 2023	BUY	$127.59 - $203.08 $674,823 - $1.07 Million	5,289 Added 99.79%	10,589 $2.14 Million
Q4 2022 Feb 06, 2023	SELL	$117.37 - $139.17 $25,821 - $30,617	-220 Reduced 3.99%	5,300 $681,000
Q3 2022 Oct 18, 2022	BUY	$135.27 - $180.11 $18,937 - $25,215	140 Added 2.6%	5,520 $755,000
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $585,397 - $964,795	5,380 New	5,380 $952,000
Q1 2022 Apr 05, 2022	SELL	$119.61 - $157.85 $682,135 - $900,218	-5,703 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$142.57 - $190.86 $2,851 - $3,817	-20 Reduced 0.35%	5,703 $882,000
Q3 2021 Oct 15, 2021	SELL	$142.45 - $169.82 $5,698 - $6,792	-40 Reduced 0.69%	5,723 $972,000
Q2 2021 Jul 21, 2021	SELL	$135.08 - $161.1 $96,987 - $115,669	-718 Reduced 11.08%	5,763 $910,000
Q1 2021 Apr 05, 2021	SELL	$137.51 - $190.8 $73,980 - $102,650	-538 Reduced 7.66%	6,481 $900,000
Q4 2020 Jan 20, 2021	BUY	$164.63 - $211.93 $1.16 Million - $1.49 Million	7,019 New	7,019 $1.23 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.